Patents by Inventor Yiumo CHAN

Yiumo CHAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20240092731
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Application
    Filed: July 14, 2023
    Publication date: March 21, 2024
    Inventors: Yiumo CHAN, Emil D. KAKKIS, Alexandra TROTIER-FAURION, William F. BRUBAKER, Arjun NATESAN, Paul LEE, Sharyl FYFFE-MARICICH, David LAPOINTE, Mike E. LIZARZABURU
  • Creatine prodrugs, compositions and methods of use thereof
    Patent number: 11753369
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Grant
    Filed: March 28, 2022
    Date of Patent: September 12, 2023
    Assignee: Ultragenyx Pharmaceutical Inc.
    Inventors: Yiumo Chan, Emil D. Kakkis, Alexandra Trotier-Faurion, William F. Brubaker, Arjun Natesan, Paul Lee, Sharyl Fyffe-Maricich, David Lapointe, Mike E. Lizarzaburu
  • CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20220227703
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Application
    Filed: March 28, 2022
    Publication date: July 21, 2022
    Inventors: Yiumo CHAN, Emil D. KAKKIS, Alexandra TROTIER-FAURION, William F. BRUBAKER, Arjun NATESAN, Paul LEE, Sharyl FYFFE-MARICICH, David LAPOINTE, Mike E. LIZARZABURU
  • Creatine prodrugs, compositions and methods of use thereof
    Patent number: 11332438
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: May 17, 2022
    Assignee: Ultragenyx Pharmaceutical Inc.
    Inventors: Yiumo Chan, Emil D. Kakkis, Alexandra Trotier-Faurion, William F. Brubaker, Arjun Natesan, Paul Lee, Sharyl Fyffe-Maricich, David Lapointe, Mike E. Lizarzaburu
  • CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20210002211
    Abstract: The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
    Type: Application
    Filed: December 3, 2018
    Publication date: January 7, 2021
    Inventors: Yiumo CHAN, Emil D. KAKKIS, Alexandra TROTIER-FAURION, William F. BRUBAKER, Arjun NATESAN, Paul LEE, Sharyl FYFFE-MARICICH, David LAPOINTE, Mike E. LIZARZABURU
  • CREATINE ANALOGS AND THE USE THEREOF
    Publication number: 20160289175
    Abstract: The present invention provides novel creatine analogs useful for treating any creatine deficiency disorders and methods of treating and preventing creatine deficiencies utilizing the present compounds and the pharmaceutical compositions or formulations thereof. Certain embodiments seek to increase the lipophilicty of novel creatine analogs with the goal of improving their bioavailability.
    Type: Application
    Filed: November 5, 2014
    Publication date: October 6, 2016
    Inventors: Steven Jungles, Yiumo Chan, Emil Kakkis
  • BIOMARKERS FOR ASSESSING TREATMENT OF SIALIC ACID DEFICIENCY DISEASES AND CONDITIONS
    Publication number: 20140113876
    Abstract: The present invention relates to methods of monitoring and assessing sialic acid deficiency treatment as well as to methods of predicting/determining responsiveness to treatment for a sialic acid deficiency using biomarkers. Sialic acid deficiencies include for example Hereditary Inclusion Body Myopathy (HIBM).
    Type: Application
    Filed: September 20, 2013
    Publication date: April 24, 2014
    Applicant: ULTRAGENYX PHARMACEUTICAL INC.
    Inventors: Yiumo CHAN, Steve JUNGLES, Emil KAKKIS
  • BIOMARKERS FOR ASSESSING TREATMENT OF SIALIC ACID DEFICIENCY DISEASES AND CONDITIONS
    Publication number: 20140094505
    Abstract: The present invention relates to methods of monitoring and assessing sialic acid deficiency treatment as well as to methods of predicting/determining responsiveness to treatment for a sialic acid deficiency using biomarkers. Sialic acid deficiencies include for example Hereditary Inclusion Body Myopathy (HIBM).
    Type: Application
    Filed: September 20, 2013
    Publication date: April 3, 2014
    Applicant: Ultragenyx Pharmaceutical Inc.
    Inventors: Yiumo CHAN, Steve Jungles, Emil Kakkis